Gender Differences in Perceptions of Psoriatic Arthritis Disease Impact, Management, and Physician Interactions: Results from a Global Patient Survey

被引:0
|
作者
Eder, Lihi [1 ]
Richette, Pascal [2 ]
Coates, Laura C. [3 ]
Azevedo, Valderilio F. [4 ]
Cappelleri, Joseph C. [5 ]
Johnson, Edward P. [6 ]
Hoang, Megan [7 ]
Moser, Jade [6 ]
Kessouri, Meriem [8 ]
机构
[1] Univ Toronto, Womens Coll Res Inst, Div Rheumatol, Toronto, ON, Canada
[2] Univ Paris, Lariboisiere Hosp, AP HP, Rheumatol Dept, Paris, France
[3] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskeleta, Oxford, England
[4] Univ Fed Parana, Hosp Clin, Dept Internal Med, Curitiba, Brazil
[5] Pfizer Inc, Stat Res & Data Sci Ctr, Groton, CT USA
[6] The Harris Poll, Media Commun Res, Rochester, NY USA
[7] Pfizer Inc, Inflammat & Immunol, New York, NY USA
[8] Pfizer France, Inflammat & Immunol, 23-25 Ave Dr Lannelongue, F-75668 Paris, France
关键词
Global survey; Patient perception; Patient-reported outcomes; Psoriatic arthritis; Gender differences; PREVALENCE; DELAY;
D O I
10.1007/s40744-024-00678-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: We evaluated the impact of gender on disease severity, health-related quality of life (HRQoL), treatment management, and patient-healthcare professional (HCP) interactions from the perspectives of patients with psoriatic arthritis (PsA). Methods: Data were collected from a global online patient survey conducted by The Harris Poll (November 2, 2017 to March 12, 2018). Eligible patients were aged >= 18 years, with a self-reported diagnosis of PsA for > 1 year, had visited a rheumatologist/dermatologist in the past 12 months, and had reported previously using >= 1 conventional synthetic or biologic disease-modifying antirheumatic drug. Data were stratified by gender and analyzed descriptively, inferentially by binomial (chi-square) tests, and by multivariate logistic regression models. Results: Data from 1286 patients who participated were included: 52% were female, 48% were male. Varying perceptions of disease severity between males and females were indicated by differences in symptoms leading to a diagnosis of PsA, and in symptoms reported despite treatment; more females than males reported joint tenderness, skin patches/plaques, and enthesitis. More females than males reported a major/moderate impact of PsA on their physical activity and emotional/mental well-being. Reasons for switching medication differed between genders, with more females switching because they perceived their medication to not be effective enough related to their joint symptoms. More females than males were very satisfied with their communication with their rheumatologist and were more likely to discuss the impact of PsA on their daily lives, their treatment satisfaction, and treatment goals with their rheumatologist. Conclusions: Patients' perceptions of the impact of PsA on HRQoL, treatment management, and interactions with HCPs varied between males and females. More females than males reported major/moderate physical and emotional impacts of PsA. When treating patients, it is important for HCPs to consider the potential impact of gender on patients' experience of PsA and its symptoms.Graphical plain language summary available for this article.
引用
收藏
页码:1115 / 1134
页数:20
相关论文
共 50 条
  • [31] Patient-Reported and Economic Racial and Ethnic Disparities in Patients with Psoriatic Arthritis: Results from the National Health and Wellness Survey
    Lin, Iris
    Krupsky, Kathryn
    Way, Nate
    Patel, Aarti A.
    Tieng, Arlene
    RHEUMATOLOGY AND THERAPY, 2024, 11 (06) : 1569 - 1590
  • [32] Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study
    Ennio Lubrano
    Silvia Scriffignano
    Ana Belen Azuaga
    Julio Ramirez
    Juan D. Cañete
    Fabio Massimo Perrotta
    Rheumatology and Therapy, 2020, 7 : 825 - 836
  • [33] Cardiovascular risk management in rheumatoid and psoriatic arthritis: Online survey results from a national cohort study
    Sinnathurai P.
    Capon A.
    Buchbinder R.
    Chand V.
    Henderson L.
    Lassere M.
    March L.
    BMC Rheumatology, 2 (1)
  • [34] Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT study
    M. Elaine Husni
    Anthony Fernandez
    Brett Hauber
    Rakesh Singh
    Joshua Posner
    Jessie Sutphin
    Arijit Ganguli
    Arthritis Research & Therapy, 20
  • [35] Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT study
    Husni, M. Elaine
    Fernandez, Anthony
    Hauber, Brett
    Singh, Rakesh
    Posner, Joshua
    Sutphin, Jessie
    Ganguli, Arijit
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [36] Patient Perspectives of the Impact of Psoriatic Disease on Quality-of-Life in India: Sub-analysis from the Global Psoriasis and Beyond Survey
    Chandrashekar, B. S.
    Nayak, Chitra S.
    Kar, Bikash R.
    Salloju, Vineeth
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2024, 15 (02) : 233 - 241
  • [37] Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort
    Tillett, William
    Birt, Julie
    Cavanaugh, Cristi
    Jung, Yoojin
    Vadhariya, Aisha
    Ross, Sarah
    Paulus, Jessica
    Lubrano, Ennio
    FRONTIERS IN MEDICINE, 2023, 10
  • [38] Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    Karki, Chitra
    Palmer, Jacqueline B.
    Etzel, Carol J.
    Kavanaugh, Arthur
    Ritchlin, Christopher T.
    Malley, Wendi
    Herrera, Vivian
    Tran, Melody
    Greenberg, Jeffrey D.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (11) : 1692 - 1699
  • [39] Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States
    Alexis Ogdie
    W. Benjamin Nowell
    Eddie Applegate
    Kelly Gavigan
    Shilpa Venkatachalam
    Marie de la Cruz
    Emuella Flood
    Ethan J. Schwartz
    Beverly Romero
    Peter Hur
    BMC Rheumatology, 4
  • [40] Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE
    Mease, Philip J.
    Asahina, Akihiko
    Gladman, Dafna D.
    Tanaka, Yoshiya
    Tillett, William
    Ink, Barbara
    Assudani, Deepak
    de la Loge, Christine
    Coarse, Jason
    Eells, Jason
    Gossec, Laure
    RHEUMATOLOGY, 2023, 62 (02) : 617 - 628